What is National Healthcare Properties's earnings per share (EPS)?

National Healthcare Properties (HLTC) reported diluted earnings per share of -$2.51 for fiscal year 2025. This represents a 65.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

National Healthcare Properties Financials

HLTC

Trailing 12 months to June 30, 2026

Revenue $344.3M -1.2% YoY

Net Income -$45.0M +43.8% YoY

EPS (Diluted) -$1.88 +43.2% YoY

Free Cash Flow Not reported for the trailing 12 months

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE December

National Healthcare Properties (HLTC) reported $344.3M in revenue over the twelve months to Jun 30, 2026, down 1.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HLTC FY2025 2026-08-06

Asset recycling and cost normalization lifted cash and operating profit, but a heavy interest burden still keeps earnings negative.

FY2025's cash recovery was transaction-driven rather than operating-driven: cash ended at $57.6M while operating cash flow was only $7.0M. The bridge is in the cash-flow mix, with $69.8M coming from investing and $42.4M used in financing, so liquidity improved mainly by shrinking or recycling the asset base rather than by the core business becoming a strong cash generator.

The margin shape is more informative than revenue here: gross margin stayed in a tight 36.0%-37.4% range from FY2023 through FY2025. Yet operating margin swung from -34.9% in FY2024 to 1.0% in FY2025, which suggests last year's damage sat below gross profit and the rebound came more from lower charges or overhead pressure than from a major change in core revenue economics.

The balance sheet became smaller without becoming easier to carry: total liabilities fell from $1.24B in FY2023 to $1.11B in FY2025. But equity also fell to $600M, pushing debt-to-equity to 1.8x; that helps explain why FY2025 still showed a net loss, because interest expense of $61.3M was far larger than operating income of $3.3M.

Financial Health Signals

Financial health score not available

National Healthcare Properties does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

4/7

National Healthcare Properties passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Mixed

N/A

National Healthcare Properties reported a net loss of $57.7M while generating $7.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

0.05x

National Healthcare Properties earns $0.05 in operating income for every $1 of interest expense ($3.3M vs $61.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$342.3M

YoY-3.3%

5Y CAGR-2.2%

10Y CAGR+3.3%

National Healthcare Properties generated $342.3M in revenue in fiscal year 2025. This represents a decrease of 3.3% from the prior year.

EBITDA

$81.6M

YoY+306.6%

5Y CAGR+5.9%

10Y CAGR-0.4%

National Healthcare Properties's EBITDA was $81.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 306.6% from the prior year.

Net Income

-$57.7M

YoY+69.7%

National Healthcare Properties reported -$57.7M in net income in fiscal year 2025. This represents an increase of 69.7% from the prior year.

EPS (Diluted)

-$2.51

YoY+65.1%

National Healthcare Properties earned -$2.51 per diluted share (EPS) in fiscal year 2025. This represents an increase of 65.1% from the prior year.

Cash & Balance Sheet

Cash & Debt

$57.6M

YoY+166.1%

5Y CAGR-4.5%

10Y CAGR+8.9%

National Healthcare Properties held $57.6M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding

28M

YoY+0.4%

National Healthcare Properties had 28M shares outstanding in fiscal year 2025. This represents an increase of 0.4% from the prior year.

Free Cash Flow

Not reported for fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin

36.0%

YoY-1.4pp

5Y CAGR-0.1pp

10Y CAGR-13.2pp

National Healthcare Properties's gross margin was 36.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.4 percentage points from the prior year.

Operating Margin

1.0%

YoY+35.9pp

5Y CAGR+6.2pp

10Y CAGR+15.3pp

National Healthcare Properties's operating margin was 1.0% in fiscal year 2025, reflecting core business profitability. This is up 35.9 percentage points from the prior year.

Net Margin

-16.9%

YoY+36.9pp

5Y CAGR+2.9pp

10Y CAGR0.0pp

National Healthcare Properties's net profit margin was -16.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 36.9 percentage points from the prior year.

Return on Equity

-9.6%

YoY+18.2pp

5Y CAGR-1.7pp

10Y CAGR-7.0pp

National Healthcare Properties's ROE was -9.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 18.2 percentage points from the prior year.

Capital Allocation

None of these metrics is reported for fiscal year 2025.

HLTC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HLTC quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13
Revenue	$344.3M	$342.3M-3.3%	$353.8M+2.3%	$345.9M+3.0%	$335.8M+2.0%	$329.4M-13.7%	$381.6M+1.8%	$374.9M+3.5%	$362.4M+16.5%	$311.2M+2.8%	$302.6M+22.3%	$247.5M+323.5%	$58.4M+3116.2%	$1.8M
Gross Profit	$130.4M	$123.4M-6.8%	$132.3M+3.3%	$128.1M+4.7%	$122.4M-0.9%	$123.5M-10.5%	$138.1M-1.9%	$140.7M-0.5%	$141.4M+13.2%	$124.9M-4.3%	$130.5M+7.0%	$121.9M+284.3%	$31.7M+1771.5%	$1.7M
SG&A Expenses	$26.3M	$24.2M+7.8%	$22.4M+18.6%	$18.9M+9.5%	$17.3M+2.7%	$16.8M-22.0%	$21.6M+5.1%	$20.5M+18.8%	$17.3M+10.2%	$15.7M+29.5%	$12.1M+24.4%	$9.7M+174.9%	$3.5M+3304.8%	$104K
Operating Income	$11.0M	$3.3M+102.7%	-$123.5M-2507.5%	-$4.7M+85.0%	-$31.5M+15.7%	-$37.4M-88.4%	-$19.9M+37.5%	-$31.8M-900.9%	-$3.2M+74.0%	-$12.2M-269.4%	-$3.3M+90.7%	-$35.6M-3.7%	-$34.3M-15794.0%	-$216K
Interest Expense	$58.3M	$61.3M-11.8%	$69.4M+5.1%	$66.1M+27.7%	$51.7M+8.0%	$47.9M-7.0%	$51.5M-8.1%	$56.1M+13.3%	$49.5M+63.5%	$30.3M+52.2%	$19.9M+92.0%	$10.4M+191.0%	$3.6M	$0
Income Tax	$291K	$161K-38.5%	$262K-13.5%	$303K+50.7%	$201K-1.0%	$203K-95.0%	$4.1M+917.8%	$399K+102.5%	$197K-69.6%	$647K+131.0%	-$2.1M+30.0%	-$3.0M-627.1%	$565K+11200.0%	$5K
Net Income	-$45.0M	-$57.7M+69.7%	-$190.3M-162.9%	-$72.4M+9.1%	-$79.6M+6.8%	-$85.4M-13.2%	-$75.5M+14.3%	-$88.1M-67.0%	-$52.8M-24.0%	-$42.5M-103.8%	-$20.9M+50.0%	-$41.7M-10.8%	-$37.7M-16948.9%	-$221K
EPS (Diluted)	-$1.88	-$2.51+65.1%	-$7.19	-$3.04+7.9%	-$3.30	-$0.82-10.8%	-$0.74+15.9%	-$0.88	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$87.5M+1.4%	$86.3M+2.1%	$84.5M-1.8%	$86.0M+0.8%	$85.3M-1.3%	$86.4M-1.5%	$87.7M-1.4%	$88.9M
Gross Profit	$33.4M+0.1%	$33.4M+6.1%	$31.5M-2.2%	$32.2M+3.3%	$31.2M+9.0%	$28.6M-13.0%	$32.8M+1.0%	$32.5M
SG&A Expenses	$6.6M+20.8%	$5.5M-36.0%	$8.5M+50.7%	$5.7M+11.7%	$5.1M+3.7%	$4.9M-11.0%	$5.5M0.0%	$5.5M
Operating Income	$5.1M-49.7%	$10.1M+253.6%	-$6.6M-377.1%	$2.4M+143.0%	-$5.5M-142.4%	$13.0M+1334.5%	-$1.1M+95.0%	-$20.9M
Interest Expense	$12.7M-13.3%	$14.7M-7.5%	$15.9M+5.3%	$15.1M-4.9%	$15.8M+9.0%	$14.5M-16.0%	$17.3M-3.9%	$18.0M
Income Tax	$47K-39.0%	$77K-23.8%	$101K+53.0%	$66K	$0+100.0%	-$6K-104.7%	$127K	$0
Net Income	-$5.4M-25.8%	-$4.3M+81.2%	-$22.8M-81.9%	-$12.5M+39.8%	-$20.8M-1275.2%	-$1.5M+91.1%	-$17.0M+58.2%	-$40.8M
EPS (Diluted)	-$0.13	-$0.27	-$0.92-64.3%	-$0.56+34.1%	-$0.85	-$0.18	-$0.72+53.8%	-$1.56

Not reported in any period shown, so not listed: Cost of Revenue, R&D Expenses.

HLTC Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HLTC quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13
Total Assets	$1.7B-12.0%	$1.9B-9.3%	$2.1B-1.6%	$2.2B-1.5%	$2.2B-3.2%	$2.3B-1.7%	$2.3B-2.2%	$2.4B+0.2%	$2.4B+8.1%	$2.2B-3.4%	$2.3B+22.2%	$1.9B+1059.6%	$160.2M
Cash & Equivalents	$57.6M+166.1%	$21.7M-53.3%	$46.4M-13.5%	$53.7M-10.2%	$59.7M-17.4%	$72.4M-24.4%	$95.7M+23.8%	$77.3M-18.0%	$94.2M+222.2%	$29.2M+19.4%	$24.5M-86.6%	$182.6M+63.3%	$111.8M
Accounts Receivable	$9.3M+58.2%	$5.8M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$1.1B-11.8%	$1.3B+0.9%	$1.2B+5.4%	$1.2B+0.6%	$1.2B-11.4%	$1.3B+8.8%	$1.2B+7.2%	$1.1B+11.9%	$1.0B+47.4%	$689.4M+3.2%	$668.0M+432.2%	$125.5M+6002.7%	$2.1M
Total Equity	$600.1M-12.3%	$684.6M-23.4%	$894.2M-9.9%	$992.6M-4.0%	$1.0B+8.0%	$957.0M-13.1%	$1.1B-10.7%	$1.2B-8.5%	$1.3B-9.9%	$1.5B-6.1%	$1.6B-7.5%	$1.7B+988.9%	$158.1M
Retained Earnings	N/A	N/A	N/A	-$1.5B-14.0%	-$1.3B-15.7%	-$1.1B-14.1%	-$971.2M-20.7%	-$804.3M-20.9%	-$665.0M-36.7%	-$486.6M-53.8%	-$316.3M-144.4%	-$129.4M-3236.9%	-$3.9M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$2.0B+16.4%	$1.7B-0.8%	$1.7B-1.6%	$1.7B-1.1%	$1.8B-4.0%	$1.8B-5.9%	$1.9B-2.6%	$2.0B
Cash & Equivalents	$245.7M+365.3%	$52.8M-8.3%	$57.6M+22.4%	$47.1M-0.1%	$47.1M-34.0%	$71.4M+229.7%	$21.7M-34.1%	$32.9M
Accounts Receivable	$7.2M-22.1%	$9.2M-0.6%	$9.3M-9.7%	$10.2M+10.0%	$9.3M+15.0%	$8.1M+38.4%	$5.8M	N/A
Total Liabilities	$919.0M-16.6%	$1.1B-0.5%	$1.1B+0.1%	$1.1B0.0%	$1.1B-3.9%	$1.2B-8.3%	$1.3B-2.6%	$1.3B
Total Equity	$1.1B+78.0%	$592.2M-1.3%	$600.1M-4.3%	$627.2M-3.1%	$647.0M-4.1%	$674.6M-1.5%	$684.6M-2.6%	$702.6M

Not reported in any period shown, so not listed: Current Assets, Inventory, Goodwill, Current Liabilities, Long-Term Debt, Retained Earnings.

HLTC Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HLTC quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13
Operating Cash Flow	$50.7M	$7.0M+108.7%	-$79.8M-469.2%	$21.6M-23.6%	$28.3M-27.2%	$38.9M-7.0%	$41.8M-11.8%	$47.4M-12.5%	$54.2M-15.3%	$64.0M-18.7%	$78.7M+14.6%	$68.7M+1162.3%	-$6.5M-746.2%	-$764K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$16.7M+29.5%	$12.9M+56.0%	$8.3M+10.7%	$7.5M+8.6%	$6.9M+753.2%	$807K	$0
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$30.7M-25.6%	$41.2M-25.9%	$55.7M-21.8%	$71.2M+15.3%	$61.8M+949.8%	-$7.3M-851.8%	-$764K
Investing Cash Flow	-$115.1M	$69.8M+9.1%	$64.0M+201.8%	-$62.8M-50.3%	-$41.8M+12.8%	-$47.9M+41.9%	-$82.5M-78.4%	-$46.2M+59.8%	-$115.1M+40.8%	-$194.4M-918.3%	-$19.1M+96.6%	-$556.8M+63.6%	-$1.5B-3193.9%	-$46.5M
Financing Cash Flow	$263.6M	-$42.4M-3047.7%	-$1.3M-102.4%	$56.0M+1105.5%	$4.6M+13.8%	$4.1M-79.0%	$19.4M+1.8%	$19.1M-61.6%	$49.7M-75.1%	$199.8M+459.6%	-$55.6M-116.7%	$332.9M-79.3%	$1.6B+911.1%	$159.1M
Dividends Paid	N/A	N/A	N/A	N/A	$0	$0-100.0%	$31.4M-39.0%	$51.4M-7.1%	$55.3M-27.9%	$76.7M+1.7%	$75.4M+13.9%	$66.2M+88.3%	$35.2M+2594.6%	$1.3M
Share Buybacks	N/A	N/A	N/A	N/A	$0	$0-100.0%	$10.5M-50.1%	$21.1M+48.7%	$14.2M-57.7%	$33.6M+175.8%	$12.2M+17.0%	$10.4M+1824.8%	$541K	$0

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$21.6M+139.7%	$9.0M-9.5%	$10.0M-2.1%	$10.2M+26.3%	$8.1M+137.9%	-$21.2M-428.9%	$6.5M+106.8%	-$95.2M
Investing Cash Flow	-$103.4M-1807.6%	-$5.4M-62.7%	-$3.3M-10.8%	-$3.0M-58.3%	-$1.9M-102.4%	$78.0M+1342.8%	$5.4M-92.7%	$74.1M
Financing Cash Flow	$277.5M+5195.4%	-$5.4M-665.0%	-$712K+90.9%	-$7.8M+73.5%	-$29.4M-553.0%	-$4.5M+80.2%	-$22.7M-190.6%	$25.0M

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

HLTC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

HLTC quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13
Gross Margin	36.0%-1.4pp	37.4%+0.4pp	37.0%+0.6pp	36.4%-1.1pp	37.5%+1.3pp	36.2%-1.4pp	37.5%-1.5pp	39.0%-1.1pp	40.1%-3.0pp	43.1%-6.1pp	49.3%-5.0pp	54.3%-39.0pp	93.3%
Operating Margin	1.0%+35.9pp	-34.9%-33.6pp	-1.4%+8.0pp	-9.4%+2.0pp	-11.4%-6.2pp	-5.2%+3.3pp	-8.5%-7.6pp	-0.9%+3.0pp	-3.9%-2.8pp	-1.1%+13.3pp	-14.4%+44.4pp	-58.8%-46.9pp	-11.9%
Net Margin	-16.9%+36.9pp	-53.8%-32.9pp	-20.9%+2.8pp	-23.7%+2.2pp	-25.9%-6.2pp	-19.8%+3.7pp	-23.5%-8.9pp	-14.6%-0.9pp	-13.7%-6.8pp	-6.9%+10.0pp	-16.9%+47.6pp	-64.5%-52.3pp	-12.2%
Return on Equity	-9.6%+18.2pp	-27.8%-19.7pp	-8.1%-0.1pp	-8.0%+0.3pp	-8.3%-0.4pp	-7.9%+0.1pp	-8.0%-3.7pp	-4.3%-1.1pp	-3.2%-1.8pp	-1.4%+1.2pp	-2.6%-0.4pp	-2.2%-2.1pp	-0.1%
Return on Assets	-3.4%+6.4pp	-9.8%-6.4pp	-3.4%+0.3pp	-3.6%+0.2pp	-3.9%-0.6pp	-3.3%+0.5pp	-3.8%-1.6pp	-2.2%-0.4pp	-1.8%-0.8pp	-0.9%+0.9pp	-1.8%+0.2pp	-2.0%-1.9pp	-0.1%
Debt-to-Equity	1.850.0x	1.83+0.4x	1.39+0.2x	1.19+0.1x	1.14-0.2x	1.39+0.3x	1.11+0.2x	0.92+0.2x	0.75+0.3x	0.460.0x	0.42+0.3x	0.07+0.1x	0.01
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	8.2%-3.2pp	11.4%-6.5pp	17.9%-5.6pp	23.5%-1.4pp	25.0%+37.4pp	-12.4%+29.6pp	-42.0%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	38.2%-0.5pp	38.7%+1.4pp	37.2%-0.2pp	37.4%+0.9pp	36.5%+3.4pp	33.1%-4.4pp	37.4%+0.9pp	36.6%
Operating Margin	5.8%-5.9pp	11.7%+19.5pp	-7.8%-10.5pp	2.8%+9.2pp	-6.5%-21.5pp	15.1%+16.3pp	-1.2%+22.3pp	-23.5%
Net Margin	-6.2%-1.2pp	-5.0%+22.0pp	-27.0%-12.4pp	-14.6%+9.8pp	-24.4%-22.7pp	-1.8%+17.7pp	-19.4%+26.4pp	-45.8%
Return on Equity	-0.5%+0.2pp	-0.7%+3.1pp	-3.8%-1.8pp	-2.0%+1.2pp	-3.2%-3.0pp	-0.2%+2.3pp	-2.5%+3.3pp	-5.8%
Return on Assets	-0.3%0.0pp	-0.3%+1.1pp	-1.3%-0.6pp	-0.7%+0.5pp	-1.2%-1.1pp	-0.1%+0.8pp	-0.9%+1.2pp	-2.0%
Debt-to-Equity	0.87-1.0x	1.860.0x	1.85+0.1x	1.76+0.1x	1.710.0x	1.71-0.1x	1.830.0x	1.83

Not reported in any period shown, so not listed: Current Ratio, FCF Margin.

Where National Healthcare Properties Ranks

Frequently Asked Questions

What is National Healthcare Properties's annual revenue?

National Healthcare Properties (HLTC) reported $342.3M in total revenue for fiscal year 2025. This represents a -3.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is National Healthcare Properties's revenue growing?

National Healthcare Properties (HLTC) revenue declined by 3.3% year-over-year, from $353.8M to $342.3M in fiscal year 2025.

Is National Healthcare Properties profitable?

No, National Healthcare Properties (HLTC) reported a net income of -$57.7M in fiscal year 2025, with a net profit margin of -16.9%.

What is National Healthcare Properties's EBITDA?

National Healthcare Properties (HLTC) had EBITDA of $81.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is National Healthcare Properties's gross margin?

National Healthcare Properties (HLTC) had a gross margin of 36.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is National Healthcare Properties's operating margin?

National Healthcare Properties (HLTC) had an operating margin of 1.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is National Healthcare Properties's net profit margin?

National Healthcare Properties (HLTC) had a net profit margin of -16.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is National Healthcare Properties's return on equity (ROE)?

National Healthcare Properties (HLTC) has a return on equity of -9.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is National Healthcare Properties's operating cash flow?

National Healthcare Properties (HLTC) generated $7.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are National Healthcare Properties's total assets?

National Healthcare Properties (HLTC) had $1.7B in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does National Healthcare Properties have outstanding?

National Healthcare Properties (HLTC) had 28M shares outstanding as of fiscal year 2025.

What is National Healthcare Properties's debt-to-equity ratio?

National Healthcare Properties (HLTC) had a debt-to-equity ratio of 1.85 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is National Healthcare Properties's return on assets (ROA)?

National Healthcare Properties (HLTC) had a return on assets of -3.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is National Healthcare Properties's Piotroski F-Score?

National Healthcare Properties (HLTC) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are National Healthcare Properties's earnings high quality?

National Healthcare Properties (HLTC) reported a net loss of $57.7M while generating $7.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can National Healthcare Properties cover its interest payments?

National Healthcare Properties (HLTC) has an interest coverage ratio of 0.05x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.